,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,SG_HEL_H283,female,Indian,59-year-old human stage,26,1.2287334593572778
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,SG_HEL_H283,female,Indian,59-year-old human stage,2,0.0945179584120983
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,SG_HEL_H283,female,Indian,59-year-old human stage,4,0.1890359168241966
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,SG_HEL_H283,female,Indian,59-year-old human stage,19,0.8979206049149339
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,SG_HEL_H283,female,Indian,59-year-old human stage,1,0.04725897920604915
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,SG_HEL_H283,female,Indian,59-year-old human stage,44,2.0793950850661624
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,SG_HEL_H283,female,Indian,59-year-old human stage,8,0.3780718336483932
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,SG_HEL_H283,female,Indian,59-year-old human stage,11,0.5198487712665406
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,SG_HEL_H283,female,Indian,59-year-old human stage,64,3.0245746691871456
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,SG_HEL_H283,female,Indian,59-year-old human stage,78,3.6862003780718333
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,SG_HEL_H283,female,Indian,59-year-old human stage,310,14.650283553875237
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,SG_HEL_H283,female,Indian,59-year-old human stage,82,3.8752362948960304
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,SG_HEL_H283,female,Indian,59-year-old human stage,47,2.22117202268431
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,SG_HEL_H283,female,Indian,59-year-old human stage,119,5.623818525519849
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,SG_HEL_H283,female,Indian,59-year-old human stage,208,9.829867674858223
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,SG_HEL_H283,female,Indian,59-year-old human stage,278,13.137996219281664
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,SG_HEL_H283,female,Indian,59-year-old human stage,82,3.8752362948960304
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,SG_HEL_H283,female,Indian,59-year-old human stage,92,4.3478260869565215
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,SG_HEL_H283,female,Indian,59-year-old human stage,65,3.0718336483931945
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,SG_HEL_H283,female,Indian,59-year-old human stage,7,0.33081285444234404
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,SG_HEL_H283,female,Indian,59-year-old human stage,122,5.765595463137997
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,SG_HEL_H283,female,Indian,59-year-old human stage,16,0.7561436672967864
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,SG_HEL_H283,female,Indian,59-year-old human stage,225,10.633270321361058
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,SG_HEL_H283,female,Indian,59-year-old human stage,188,8.88468809073724
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,SG_HEL_H283,female,Indian,59-year-old human stage,18,0.8506616257088847
